Biden administration could reclassify marijuana as less risky drug
May 01, 2024
The Justice Department has recommended that marijuana be reclassified as a less dangerous drug, a move that signals a significant shift in US drug policy.
AI provides mostly accurate answers to primary care questions
Apr 09, 2024
The authors say the findings still emphasize the importance of viewing AI tools as complementary resources when seeking medical information.
Smartphone-based measures can help ID frontotemporal lobar degeneration
Apr 01, 2024
Individuals with frontotemporal lobar degeneration were accurately differentiated from controls with smartphone tests.
First OTC continuous blood glucose monitor cleared for marketing by FDA
Mar 06, 2024
The Dexcom Stelo Glucose Biosensor System is intended for people aged 18 or more years who have type 2 diabetes but do not take insulin.
Free COVID test orders to end on March 8
Mar 06, 2024
Americans will not be able to order free at-home COVID tests after Friday, US health officials announced Tuesday.
Recreational marijuana laws tied to increase in workplace injuries
Mar 01, 2024
The findings were seen for young adults aged 20 to 34 years.
Eye ointments sold at Walmart, CVS recalled due to infection risk
Feb 27, 2024
Eye ointment products made in India and sold in the United States at Walmart, CVS and other retailers are being recalled due to a danger of infection.
FDA warns of smartwatches that claim to measure glucose levels
Feb 22, 2024
Many companies are illegally marketing smartwatch or smart ring devices that claim to measure blood glucose without piercing the skin.
Timing of CSF biomarker divergence for Alzheimer’s disease, normal cognition varies
Feb 21, 2024
Estimated times of divergence of cerebrospinal fluid biomarkers vary from 18 years for Aβ42 to six years for cognitive decline.
Primary care-based housing program can cut healthcare use
Feb 08, 2024
Patients in the program who obtained new housing reported mental and physical health benefits.